Plain-English translation of NCT07057375 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called pulsed electromagnetic field (PEMF) therapy to help prostate cancer patients preserve muscle mass and strength. Men with prostate cancer who receive hormone therapy often lose muscle, which can affect their quality of life. This study will see whether the treatment can help prevent or reduce this muscle loss.
A common side effect of hormone therapy for prostate cancer is muscle loss, which can weaken patients and reduce their independence. Researchers want to find out if this non-invasive electromagnetic therapy might help protect muscle during cancer treatment.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic once a week for 12 weeks. During each visit, your thigh muscles would be placed in a special machine for about 10 minutes per leg to receive the electromagnetic field therapy. You would have assessments at the start, at week 5, and at week 12 — including measurements of your muscle mass and strength, blood and urine tests, and questionnaires about how you're feeling. Half of participants will receive the active treatment, and half will receive a sham (placebo) treatment to compare results.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
Hong Kong